BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8839544)

  • 1. Racial differences in timeliness of follow-up after abnormal screening mammography.
    Chang SW; Kerlikowske K; Nápoles-Springer A; Posner SF; Sickles EA; Pérez-Stable EJ
    Cancer; 1996 Oct; 78(7):1395-402. PubMed ID: 8839544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive predictive value of screening mammography by age and family history of breast cancer.
    Kerlikowske K; Grady D; Barclay J; Sickles EA; Eaton A; Ernster V
    JAMA; 1993 Nov; 270(20):2444-50. PubMed ID: 8230621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate and Timeliness of Diagnostic Evaluation and Biopsy After Recall From Screening Mammography in the National Mammography Database.
    Oluyemi ET; Grimm LJ; Goldman L; Burleson J; Simanowith M; Yao K; Rosenberg RD
    J Am Coll Radiol; 2024 Mar; 21(3):427-438. PubMed ID: 37722468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of age, breast density, and family history on the sensitivity of first screening mammography.
    Kerlikowske K; Grady D; Barclay J; Sickles EA; Ernster V
    JAMA; 1996 Jul; 276(1):33-8. PubMed ID: 8667536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to diagnostic resolution after abnormal mammography: a review of the literature.
    Wujcik D; Fair AM
    Cancer Nurs; 2008; 31(5):E16-30. PubMed ID: 18772653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance and self-reported barriers to follow-up of abnormal screening mammograms among women utilizing a county mobile mammography van.
    Peek ME; Han JH
    Health Care Women Int; 2009 Oct; 30(10):857-70. PubMed ID: 19742361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inadequate follow-up of abnormal screening mammograms: findings from the race differences in screening mammography process study (United States).
    Jones BA; Dailey A; Calvocoressi L; Reams K; Kasl SV; Lee C; Hsu H
    Cancer Causes Control; 2005 Sep; 16(7):809-21. PubMed ID: 16132791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timeliness of follow-up after abnormal screening mammography.
    Kerlikowske K
    Breast Cancer Res Treat; 1996; 40(1):53-64. PubMed ID: 8888152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inadequate follow-up of abnormal mammograms.
    McCarthy BD; Yood MU; Boohaker EA; Ward RE; Rebner M; Johnson CC
    Am J Prev Med; 1996; 12(4):282-8. PubMed ID: 8874693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timely care after an abnormal mammogram among low-income women in a public breast cancer screening program.
    Lobb R; Allen JD; Emmons KM; Ayanian JZ
    Arch Intern Med; 2010 Mar; 170(6):521-8. PubMed ID: 20233801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delays in Follow-up Care for Abnormal Mammograms in Mobile Mammography Versus Fixed-Clinic Patients.
    Vang SS; Dunn A; Margolies LR; Jandorf L
    J Gen Intern Med; 2022 May; 37(7):1619-1625. PubMed ID: 35212876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delay in diagnostic testing after abnormal mammography in low-income women.
    Wujcik D; Shyr Y; Li M; Clayton MF; Ellington L; Menon U; Mooney K
    Oncol Nurs Forum; 2009 Nov; 36(6):709-15. PubMed ID: 19887359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
    May DS; Lee NC; Nadel MR; Henson RM; Miller DS
    AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey.
    Yabroff KR; Breen N; Vernon SW; Meissner HI; Freedman AN; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):723-32. PubMed ID: 15159302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timeliness of abnormal screening and diagnostic mammography follow-up at facilities serving vulnerable women.
    Goldman LE; Walker R; Hubbard R; Kerlikowske K;
    Med Care; 2013 Apr; 51(4):307-14. PubMed ID: 23358386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial differences in follow-up of abnormal mammography findings among economically disadvantaged women.
    Adams SA; Smith ER; Hardin J; Prabhu-Das I; Fulton J; Hebert JR
    Cancer; 2009 Dec; 115(24):5788-97. PubMed ID: 19859902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for breast cancer in women undergoing mammography.
    Reuter KL; Baker SP; Krolikowski FJ
    AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast and cervical cancer screening in obese minority women.
    Ferrante JM; Chen PH; Jacobs A
    J Womens Health (Larchmt); 2006 Jun; 15(5):531-41. PubMed ID: 16796480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving follow-up to abnormal breast cancer screening in an urban population. A patient navigation intervention.
    Battaglia TA; Roloff K; Posner MA; Freund KM
    Cancer; 2007 Jan; 109(2 Suppl):359-67. PubMed ID: 17123275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive symptoms among women with an abnormal mammogram.
    Alderete E; Juarbe TC; Kaplan CP; Pasick R; Pérez-Stable EJ
    Psychooncology; 2006 Jan; 15(1):66-78. PubMed ID: 15816053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.